• 1. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acids

Comprehensive Overview of 3,5-Dichloro-4-fluorobenzoic acid (CAS No. 98191-30-1): Properties, Applications, and Industry Insights

3,5-Dichloro-4-fluorobenzoic acid (CAS No. 98191-30-1) is a halogen-substituted benzoic acid derivative that has garnered significant attention in pharmaceutical and agrochemical research. With its unique molecular structure featuring chloro and fluoro substituents, this compound serves as a critical intermediate in synthesizing advanced active ingredients. Its chemical stability and reactivity make it indispensable for designing novel compounds with enhanced bioactivity.

The growing demand for halogenated aromatic compounds in drug discovery aligns with trends in precision medicine and sustainable agriculture. Researchers frequently explore 3,5-Dichloro-4-fluorobenzoic acid for its potential in developing crop protection agents and small-molecule therapeutics. A surge in Google searches for terms like "fluorobenzoic acid derivatives in drug design" and "chloro-fluoro benzoic acid applications" reflects industry interest in optimizing such building blocks.

From a synthetic chemistry perspective, the electron-withdrawing effects of its substituents enhance the compound’s utility in cross-coupling reactions and carboxyl group modifications. Recent studies highlight its role in creating proteolysis-targeting chimeras (PROTACs), a hot topic in oncology research. This aligns with frequent queries about "halogenated benzoic acids in targeted protein degradation" across academic forums.

Environmental considerations are paramount when discussing halogenated compounds. Manufacturers of 3,5-Dichloro-4-fluorobenzoic acid increasingly adopt green chemistry principles to minimize waste, responding to searches for "eco-friendly synthesis of fluorinated aromatics". Analytical techniques like HPLC-MS and NMR spectroscopy ensure rigorous quality control, addressing concerns about compound purity in peer-reviewed literature.

The compound’s crystalline properties and solubility profile (often searched as "3,5-Dichloro-4-fluorobenzoic acid solubility in organic solvents") facilitate its formulation in various industrial processes. Patent databases reveal its incorporation into electronic materials, particularly for organic semiconductors, showcasing versatility beyond life sciences.

Regulatory compliance remains a key discussion point, with REACH and FDA guidelines shaping production standards. Laboratories handling 98191-30-1 prioritize safe handling protocols, reflecting search trends around "halogenated acid storage best practices". The compound’s thermal stability data (commonly queried as "decomposition temperature of 3,5-Dichloro-4-fluorobenzoic acid") is crucial for process safety assessments.

Emerging applications in bioconjugation chemistry position this compound as a tool for developing diagnostic probes and biomaterials. The rise of click chemistry methodologies has renewed interest in its carboxyl activation potential, evident from citations in recent ACS journal publications. This intersects with frequent searches for "fluorobenzoic acid linker molecules" in biotech circles.

Market analysts note steady growth in the fine chemicals sector for such intermediates, driven by pharmaceutical outsourcing trends. Suppliers emphasize batch-to-batch consistency and regulatory documentation—topics frequently appearing in procurement RFPs for CAS 98191-30-1. Technical datasheets typically include detailed spectral characterization to meet researcher demands for structural verification data.

In academic settings, 3,5-Dichloro-4-fluorobenzoic acid serves as a model compound for teaching electrophilic aromatic substitution principles. Its structure-activity relationships are often compared to simpler benzoic acids in medicinal chemistry coursework, corresponding to search terms like "teaching halogen effects in organic chemistry". The compound’s X-ray crystallography data provides valuable insights into molecular packing phenomena.

Future research directions may explore its metal-organic framework (MOF) applications or catalytic uses, areas generating substantial scholarly attention. The compound’s balanced lipophilicity (logP ~2.8) makes it particularly interesting for ADME studies, a recurring theme in pharmacokinetics optimization discussions. These facets ensure 98191-30-1 remains relevant across multiple scientific disciplines.

• 403-17-8(4-Chloro-3-fluorobenzoic acid)
• 86522-89-6(2,4-Dichloro-5-fluorobenzoic acid)
• 214774-58-0(2,4-dichloro-5-fluoro-3-formylbenzoic acid)
• 195457-73-9([1,1'-Biphenyl]-4-carboxylicacid, 3'-chloro-4'-fluoro-)
• 844878-86-0([1,1'-Biphenyl]-4-carboxylicacid, 4'-chloro-3'-fluoro-)
• 25026-64-6(3-Chloro-5-fluorobenzoic acid)
• 403-16-7(3-Chloro-4-fluorobenzoic acid)
• 13656-36-5(3,5-Dichloro-2,4,6-trifluorobenzoic acid)
• 178813-78-0(2,6-Dichloro-3-fluorobenzoic acid)
• 150444-95-4(3-Chloro-4,5-difluorobenzoic acid)